Freshfields and Homburger advised BIOTRONIK on the deal. BIOTRONIK Group, a leading global medical technology company based in Berlin, Germany, has entered into an agreement to...
Teleflex’s Acquisition Teleflex’s $791 Million Acquisition Of VI Business From BIOTRONIK GroupVascular Intervention Business of BIOTRONIK
Molecular Partners AG’s $20 Million Underwritten Offering of American Depositary Shares
Homburger advised Molecular Partners AG on the offering. Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin...
Addex Therapeutics Ltd’s Launch of Neurosterix
Homburger advised Addex Therapeutics Ltd., Advestra acted for Perceptive Advisors. Addex Therapeutics, a clinical-stage biopharmaceutical company, listed on the SIX Swiss Exchange and on the Nasdaq,...
Nice & Green SA’ Renegotiation of Its Investment in Evolva Holding
Homburger advises Nice & Green SA on the renegotiation of its investment in an equity-linked convertible notes debt instrument issued by Evolva Holding SA. Evolva Holding...
Addex Therapeutics’ New PIPE Transaction
Homburger advised Addex Therapeutics on the deal. The allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has completed an equity financing...
Santhera’s Shares Private Placement and Upsizing of Existing Financing
Homburger advised Santhera on the deal. Santhera Pharmaceuticals Holding AG (SIX: SANN) announced a private placement of shares and an amendment of its existing financing with...
StoneX’s Acquisition of Cotton Distributors Inc.
Homburger advised StoneX in this transaction. Lenz & Staehelin advised CDI’s sole shareholder and seller. StoneX Group Inc. (NASDAQ: SNEX), a global financial services company, announced...
DSM’s Merger With Firmenich
Clifford Chance has advised J.P. Morgan on the bridge financing facility of EUR 3.0 billion in connection with the merger of DSM-Firmenich. Homburger AG advised Sentarom...
Addex Therapeutics’ PIPE Transaction With Armistice Capital
Homburger advised Addex in this transaction. Allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has entered into a definitive agreement...
KKR’s Investment in Biosynth Carbosynth
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
anthera Pharmaceuticals’ CHF 15 Million Private Convertible Bonds And CHF 10 Million Exchangeable Notes
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...